Log in to search using one of your social media accounts:

 

CathVision inks investment deal for electrophysiology system

Early-stage medical device company CathVision said today it inked a “multi-million venture investment” to support the development and marketing of its electrophysiology recording system designed for treating cardiac arrhythmia. The undisclosed investment came from Scandanavian-based VF Venture and Borean Innovation, Denmark-based CathVision said. “CathVision works in one of the fastest growing segments in medical technology. CathVision’s team has worked patiently and consistently with their product over a number of years, and we have followed the company for several years. I think CathVision represents an attractive investment target in a market with high activity,” VF Venture managing partner Tonni Bülow-Nielsen said in a prepared statement. “CathVision is one of the investments we have high expectations for. We have been on board since 2014 and we have now completed three capital raises in the company. We are very satisfied with the syndicate with VF Venture and look forward to the joint work towards market approval and roll-out,” Borean Innovation portfolio manager Lene Gerlach said in preapred remarks. CathVision develops and produces a low-noise EP system designed to help guide medical professionals to the right locations for cardiac ablation. The company said it is working with leading physicians and electrophysiologists to test and market the system, and that the new investment will allow the company to conduct clinical te...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Cardiovascular cathvision Source Type: news

Related Links:

CONCLUSIONS: It is important that clinicians managing gastroparesis are aware of the arrhythmogenic potential of drugs used clinically and risk factors that contribute to QT prolongation to safeguard patients at risk for drug-induced cardiac arrhythmia. PMID: 29157021 [PubMed - as supplied by publisher]
Source: Scandinavian Journal of Gastroenterology - Category: Gastroenterology Tags: Scand J Gastroenterol Source Type: research
The folks at Abbott received FDA clearance for the Confirm Rx implantable cardiac monitoring device that wirelessly connects to the patient’s smartphone. Cardiac recordings pass from the device to the smartphone and then onto the company’s online portal where cardiologists can view the data at any time. By being able to immediately share events with the physician, patients can be diagnosed quicker whether and what kind of cardiac arrhythmias they may have. The patient simply installs the myMerlin app on their phone and uses Bluetooth to sync to the implant. A schedule is set to move saved data from the device, ...
Source: Medgadget - Category: Medical Devices Authors: Tags: News Source Type: blogs
ObjectiveTo investigate the associations between age, vascular health, and Alzheimer disease (AD) imaging biomarkers in an elderly sample. MethodsWe identified 430 individuals along the cognitive continuum aged>60 years with amyloid positron emission tomography (PET), tau PET, and magnetic resonance imaging (MRI) scans from the population‐based Mayo Clinic Study of Aging. A subset of 329 individuals had fluorodeoxyglucose (FDG) PET. We ascertained presently existing cardiovascular and metabolic conditions (CMC) from health care records and used the summation of presence/absence of hypertension, hyperlipidemia, cardiac...
Source: Annals of Neurology - Category: Neurology Authors: Tags: Research Article Source Type: research
Abbott Laboratories acquired St. Jude Medical earlier this year knowing that the company trailed behind its peers in the cardiac rhythm management (CRM) space by not having a MRI-compatible pacemaker or implantable cardioverter defibrillator (ICD) system. It seems Abbott has officially caught up in that category though, first with FDA approval of the Assurity MRI pacemaker and the Tendril MRI pacing lead during the first quarter, and now with FDA approval of MRI-conditional labeling for the Ellipse ICD system. Abbott said the recent approval covers one of its most widely-used ICD systems and associated high voltage leads. ...
Source: MDDI - Category: Medical Devices Authors: Tags: MD & M Minneapolis Labeling Business Source Type: news
AbstractCardiac amyloidosis is a form of restrictive cardiomyopathy resulting in heart failure and potential risk on arrhythmia, due to amyloid infiltration of the nerve conduction system and the myocardial tissue. The prognosis in this progressive disease is poor, probably due the development of cardiac arrhythmias. Early detection of cardiac sympathetic innervation disturbances has become of major clinical interest, because its occurrence and severity limits the choice of treatment. The use of iodine-123 labelled metaiodobenzylguanidine ([I-123]MIBG), a chemical modified analogue of norepinephrine, is well established in...
Source: Journal of Nuclear Cardiology - Category: Nuclear Medicine Source Type: research
BioSig Technologies, a company out of Minneapolis, Minnesota, touts its PURE EP technology as superior electrophysiology (EP) signal recording and processing system compared to conventional devices, and is positioned to shake-up the EP market when it is launched in 2018. An animal laboratory study utilizing the PURE EP system was recently published in the Journal of Innovations in Cardiac Rhythm Management, showcasing its ability to detect cells that cause deadly arrhythmias. Trials were conducted by a team of cardiologists and electrophysiologists from Mayo Clinic, Harvard’s Brigham &Women’s, and...
Source: Medgadget - Category: Medical Devices Authors: Tags: News Source Type: blogs
Vipera berus has a worldwide distribution and causes high morbidity in dogs annually. A complication to envenomation may be cardiac arrhythmias. The purpose of this study was to invest...
Source: Acta Veterinaria Scandinavica - Category: Veterinary Research Authors: Source Type: research
ConclusionsThis DM mutant mouse model presented with clinical myofibril ultrastructural abnormality and cardiac arrhythmias, including atrial tachyarrhythmias, atrioventricular block, and ventricular tachyarrhythmias. Optical mapping studies revealed prolonged action potential duration and slow conduction velocity in the DM mice, leading to vulnerability of spatially discordant alternans and ventricular arrhythmia induction to pacing.
Source: JAHA:Journal of the American Heart Association - Category: Cardiology Authors: Tags: Arrhythmias, Basic Science Research Original Research Source Type: research
Medtronic won FDA clearance for its Reveal LINQ Insertable Cardiac Monitor with TruRhythm Detection. The device is used to spot and analyze difficult to diagnose arrhythmias over periods as long as three years. It is an upgrade of the original Reveal LINQ, now sporting algorithms that significantly reduce the number of false positive cases of atrial fibrillation, bradycardia, and false pause episodes. About as tall as a standard AAA, it is much thinner and is only about a third of its volume. It is implanted in the chest, just under the skin, not too far from the heart. The device continuously monitors the heart ...
Source: Medgadget - Category: Medical Equipment Authors: Tags: Cardiology Medicine Source Type: blogs
Severe accidental hypothermia can cause circulatory disturbances ranging from cardiac arrhythmias through circulatory shock to cardiac arrest. Severity of shock, pulmonary hypoperfusion and ventilation-perfusi...
Source: Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine - Category: Emergency Medicine Authors: Source Type: research
More News: Arrhythmia | Cardiac Arrhythmia | Cardiology | Cardiovascular | Denmark Health | Heart | Hospitals | Marketing | Medical Devices | PET Scan